Dialysis-related Biomarker at Time of Death (Postmortem Analysis)

What This Test Measures

This test may analyze substances like electrolytes, waste products, or proteins that are typically monitored during dialysis. These markers help identify whether the person received dialysis treatment before passing away. The exact substances tested could include sodium, potassium, urea, creatinine, or other indicators of fluid balance and kidney function.

Why It Might Be Done

Postmortem tests like this are often conducted in legal or medical investigations to clarify circumstances around death, especially if dialysis was suspected. Healthcare providers or legal professionals may request this analysis to assess whether dialysis was administered and its potential impact on the individual’s condition.

What to Expect

Since this test is performed after death, there are no direct patient instructions. The sample (e.g., blood, serum, or plasma) is collected by authorized personnel and sent to a laboratory for analysis. Results are typically reviewed by medical or legal experts rather than shared directly with the patient’s family.

Possible Findings

Findings may indicate exposure to dialysis by showing elevated or altered levels of specific biomarkers compared to natural postmortem changes. For example, high urea or creatinine levels might suggest recent dialysis treatment. However, interpretation depends on the context of the case and may require expert evaluation.